MGX

Quote

Short

News

Articles

Message Board

Metagenomi Therapeutics Inc Com (NASDAQ : MGX ) News

Metagenomi Therapeutics Inc Com (NASDAQ: MGX) News Releases

MGX News Releases

May 28, 2026 08:00:00 am

GlobeNewswire

Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference

May 11, 2026 04:05:00 pm

GlobeNewswire

Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results

April 16, 2026 07:00:00 am

GlobeNewswire

Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency

April 13, 2026 12:15:00 pm

PR Newswire

Did Metagenomi Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

March 07, 2026 04:30:45 am

US Earnings Reports

Expected earnings - Metagenomi Therapeutics Inc Com

March 05, 2026 05:00:48 pm

SeekingAlpha

Metagenomi GAAP EPS of -$2.36 in-line, revenue of $25.2M misses by $3.43M

March 05, 2026 04:05:00 pm

GlobeNewswire

Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results

March 04, 2026 02:22:18 pm

SeekingAlpha

Metagenomi Therapeutics, Inc. (MGX) Presents at TD Cowen 46th Annual Health Care Conference Transcript

February 23, 2026 04:05:00 pm

GlobeNewswire

Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference

January 12, 2026 08:30:00 am

GlobeNewswire

Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account